Dr. Moritz Stolla receives work order from the Cerus Corporation

Dr. Stolla was recently engaged by the Cerus Corporation for continued work on their project related to the “Recovery and Survival of Radiolabeled INTERCEPT (a Blood System for Platelets Pathogen Reduction) Apheresis Platelet Components.”